Netherlands· NL-0c4a20618cf6

Syntocinon 5 IE/ml, oplossing voor injectie/infusie

A oxytocin product containing oxytocine, registered in Netherlands by Alfasigma S.p.A.. The same ATC class is registered in 16 of our 19 countries.

ATC H01BB02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about oxytocineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Oxytocin is registered in 16 of 19 countries.

Countries holding a registration under ATC H01BB02 (oxytocin), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search oxytocin products by name

Oxytocin · ATC H01BB02

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: OXYTOCINE
Manufacturer: Alfasigma S.p.A.
Country: Netherlands (NL)
ATC code: H01BB02
ATC class: Oxytocin
Defined daily dose: 15 E, N
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
03714

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

303 interactions on record for oxytocin.

Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check oxytocin against other medicines How interaction checks work

Oxytocin · interactions on record

303 records

71 severe
228 moderate
3 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
QuinidineC01BA01severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxytocin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxytocin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Oxytocin Grindeks, Syntocinon
Belgium · Oxytocin Grindeks, Syntocinon
Bulgaria · Окситоцин Pихtep
Cyprus · Syntocinon
Czechia · Ofost, Oxytocin Avmc
Germany · Oxytocin Hexal, Oxytocin Panpharma
Denmark · Oxytocin Orifarm, Syntocinon
Estonia · Oxytocin Grindeks
Spain · Oxitocina Grindeks, Syntocinon
Finland · Oxytocin Orifarm, Syntocinon
France · Oxytocine Ever Pharma, Oxytocine Grindeks
United Kingdom (Northern Ireland) · Oxytocin, Oxytocin Hameln Pharma
Greece · Oxytocin Gap
Croatia · Syntocinon
Hungary · Oxytocin Grindeks, Oxytocin Panpharma
Ireland · Ofost, Oxytocin Pinewood Laboratories
Iceland · Syntocinon
Italy · Ossitocina Grindeks, Syntocinon
Lithuania · Ofost, Oxytocin Grindeks
Latvia · Ofost, Oxytocin Grindeks
Malta · Oxytocin Wockhardt, Syntocinon
Norway · Oxytocin Cd Pharma, Oxytocin Orifarm
Poland · Oxytocin Grindeks, Oxytocin Grindex
Portugal · Oxitocina Generis, Oxitocina Grindeks
Romania · Ofost, Oxitocină Panpharma
Sweden · Oxytocin Cd Pharma, Oxytocin Grindeks
Slovenia · Ofost, Syntocinon
Slovakia · Ofost, Oxygrindeks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f0b27927-a42f-40cd-acdc-7247ce1c7451
GET /v1/drugs/f0b27927-a42f-40cd-acdc-7247ce1c7451?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie of infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h03714_smpc.pdf",
  "strength": null,
  "atc_label": "Oxytocin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg03714",
  "excipients": [
    "AZIJNZUUR (E 260), GECONCENTREERD",
    "NATRIUMACETAAT 3-WATER (E 262)",
    "NATRIUMCHLORIDE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "OXYTOCINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h03714.pdf",
  "authorised_at": "1990/05/20",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "03714",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about oxytocin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console